Medical Oncologists' Views on the Utility of Medical Marijuana Across the Cancer Trajectory

被引：7

作者：

Braun, Ilana M. ^{[1
,2
,3
]}

Blonquist, Traci M. ^{[1
]}

Campbell, Eric G. ^{[2
,4
]}

Nayak, Manan M. ^{[1
,5
]}

Bolcic-Jankovic, Dragana ^{[5
]}

Wright, Alexi A. ^{[1
,2
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] Harvard Med Sch, Boston, MA 02115 USA

[3] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA

[4] Univ Colorado, Anschutz Med Campus, Denver, CO 80202 USA

[5] Univ Massachusetts, Boston, MA 02125 USA

来源：

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | 2019年 / 57卷 / 06期

关键词：

D O I：

10.1016/j.jpainsymman.2019.02.001

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

引用

页码：E1 / E4

页数：4

共 6 条

[1]

[Anonymous], HLTH EFF CANN CANN

[2]

Braun IM, 2018, JCO, V36, P1957

[3] DELTA-9-TETRAHYDROCANNABINOL AS AN ANTI-EMETIC IN CANCER-PATIENTS RECEIVING HIGH-DOSE METHOTREXATE - PROSPECTIVE, RANDOMIZED EVALUATION [J].

CHANG, AE ;

SHILING, DJ ;

STILLMAN, RC ;

GOLDBERG, NH ;

SEIPP, CA ;

BAROFSKY, I ;

SIMON, RM ;

ROSENBERG, SA .

ANNALS OF INTERNAL MEDICINE, 1979, 91 (06) :819-824

[4]

Musty RE, 2001, J CANNABIS THER, V1, P25

[5]

R Development Core Team, 2011, R LANG ENV STAT COMP

[6] Anticancer mechanisms of cannabinoids [J].

Velasco, G. ;

Sanchez, C. ;

Guzman, M. .

CURRENT ONCOLOGY, 2016, 23 :S23-S32

← 1 →